An Efficient Preparation of
ꢀ-Aryl-ꢀ-ketophosphonates by the TFAA/
H3PO4-Mediated Acylation of Arenes with
Phosphonoacetic Acids
generally utilize the same basic strategy of elaborating a benzoyl
derivative to the targeted ketophosphonate (Scheme 1). Ad-
ditionally, many of the literature methods require the use of
strong base and cryogenics, which can limit their utility in
certain instances.
George P. Luke,* Christopher K. Seekamp, Zhe-Qing Wang,
and Bertrand L. Chenard
Process Chemistry, Neurogen Corporation,
Branford, Connecticut 06405
As part of a recent development project, we required supplies
of several novel ꢀ-aryl-ꢀ-ketophosphonates (1, Scheme 2),
which were to be used in subsequent HWE reactions in the
preparation of key acrylophenone intermediates. These closely
related 2,3-dimethylphenol derivatives differ primarily in the
length of the hydroxyalkyl chain appended to the phenol oxygen.
In considering a strategy for the preparation of 1, we recognized
that the only commercially available derivative of 2,3-dimeth-
ylphenol that appeared to be a suitable substrate for the existing
methods of preparing ꢀ-aryl-ꢀ-ketophosphonates was 2,3-
dimethylanisaldehyde, which was rather expensive. Preparing
related benzoyl derivatives to serve as suitable substrates for
existing methods would only add steps to our process. Further-
more, the reaction conditions used in some of the existing
methods were not compatible with some of the functionality in
our system and/or were not attractive from a process chemistry
standpoint. We therefore began to consider alternative methods
of preparing ꢀ-aryl-ꢀ-ketophosphonates. The goal was to
identify an efficient process that utilizes relatively mild reaction
conditions. We knew that the Friedel-Crafts acylation of 2,3-
dimethylanisole (2a) with simple acid chlorides was a regiose-
lective, high-yielding reaction,5 so we considered an approach
whereby we would use a phosphonoacetic acid to acylate an
appropriate 2,3-dimethylphenol derivative (2, Scheme 2), di-
rectly affording a ꢀ-aryl-ꢀ-ketophosphonate. This successful
strategy is the subject of this paper.
At the outset, we considered using the known dieth-
ylphosphonoacetyl chloride,6 prepared from commercially avail-
able diethylphosphonoacetic acid (3a), in the Friedel-Crafts
acylation; however, we experienced some difficulties in isolating
the acid chloride. We therefore quickly turned our attention to
the more direct approach of using diethylphosphonoacetic acid
(3a) itself in the acylation. 2,3-Dimethylanisole (2a) was chosen
as the model substrate for surveying various reaction conditions.
We had little success using some of the more common promoters
of Friedel-Crafts acylations with carboxylic acids, such as
MeSO3H, H2SO4, trifluoroacetic anhydride (TFAA), or POCl3.
ReceiVed May 6, 2008
ꢀ-Aryl-ꢀ-ketophosphonates can be efficiently prepared in
good yield by using a TFAA/85% H3PO4-mediated acylation
of electron-rich arenes with phosphonoacetic acids. The
conditions offer advantages over existing methods of prepar-
ing these useful compounds by not requiring the use of strong
base, cryogenics, or an anhydrous and inert atmosphere.
Furthermore, some functional groups not tolerated with the
reaction conditions used in existing methods are compatible
with the herein described conditions.
ꢀ-Aryl-ꢀ-ketophosphonates (I) are frequently used reagents
in Horner-Wadsworth-Emmons (HWE) olefination reactions
with aldehydes or ketones to produce acrylophenones (II, eq
1).1 Furthermore, ꢀ-aryl-ꢀ-ketophosphonates can serve as
precursors in the preparation of γ-aryl-γ-ketophosphonates,2a
certain ꢀ-phosphonic acid R-amino acid derivatives,2b as well
as aryl-substituted 3-furylphosphonates.2c In addition to their
synthetic utility, ꢀ-aryl-ꢀ-ketophosphonates are known to pos-
sess a range of biological activity.3 Some ꢀ-aryl-ꢀ-ketophos-
phonates inhibit the proliferation of tumor cells,3a some possess
bone anabolic activity,3b and others have been identified as
thyroid receptor ligands.3c
Several methods of preparing ꢀ-aryl-ꢀ-ketophosphonates have
been described in the literature.4 All of the literature methods
(b) Arcoria, A.; Fisichella, S. Ann. Chim. 1967, 57, 1228. (c) Sampson, P.;
Hammond, G. B.; Wiemer, D. F. J. Org. Chem. 1986, 51, 4342. (d) Calog-
eropoulou, T.; Hammond, G. B.; Wiemer, D. F. J. Org. Chem. 1987, 52, 4185.
(e) Savignac, P.; Coutrot, P. Synthesis 1978, 682. (f) Kim, D. Y. Bull. Korean
Chem. Soc. 1997, 18, 339. (g) Kim, D. Y.; Kong, M. S.; Lee, K. J. Chem. Soc.,
Perkin Trans. 1 1997, 1361. (h) Kim, D. Y.; Kong, M. S.; Rhie, D. Y. Synth.
Commun. 1995, 25, 2865. (i) Kim, D. Y.; Kong, M. S.; Kim, T. H. Synth.
Commun. 1996, 26, 2487. (j) Lee, K.; Wiemer, D. F. J. Org. Chem. 1991, 56,
5556.
(1) For a review, see: Marynoff, B. E.; Reitz, A. B. Chem. ReV. 1989, 89,
863.
(2) (a) Verbicky, C. A.; Zercher, C. K. J. Org. Chem. 2000, 65, 5615. (b)
Kjærsgaard, A.; Jørgensen, K. A. Org. Biomol. Chem. 2005, 3, 804. (c) Ruzziconi,
R.; Couthon-Gourve`s, H.; Gourve`s, J.-P.; Corbel, B. Synlett 2001, 703.
(3) (a) Nguyen, L. M.; Diep, V. V.; Phan, H. T.; Niesor, E. J.; Masson, D.;
Guyon-Gellin, Y.; Buattini, E.; Severi, C.; Azoulay, R.; Bentzen, C. L. WO
2004026242, 2004. (b) Nguyen, L. M.; Diep, V. V.; Phan, H. T.; Niesor, E. J.;
Masson, D.; Guyon-Gellin, Y.; Buattini, E.; Severi, C.; Azoulay, R.; Bentzen,
C. L. WO 2004026245, 2004. (c) Erion, M. D.; Jiang, H.; Boyer, S. H. U.S.
20060046980, 2006.
(5) Cragoe, E. J.; Woltersdorf, O. W.; Gould, N. P.; Pietruszkiewicz, A. M.;
Ziegler, C.; Sakurai, Y.; Stokker, G. E.; Anderson, P. S.; Bourke, R. S.;
Kimelberg, H. K.; Nelson, L. R.; Barron, K. D.; Rose, J. R.; Szarowski, D.;
Popp, A. J.; Waldman, J. B. J. Med. Chem. 1986, 29, 825.
(4) (a) Corey, E. J.; Kwiatkowski, G. T. J. Am. Chem. Soc. 1966, 88, 5654.
(6) Coutrot, P.; Ghribi, A. Synthesis 1986, 661.
10.1021/jo800973e CCC: $40.75
Published on Web 07/22/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 6397–6400 6397